|
1. Biologie
|
|
|
|
Stopping cancer’s scrum for survival [Cancer Research UK]
|
|
|
|
|
|
New
research from our scientists in Edinburgh – led by Professor Margaret
Frame and published in the journal Cell – suggests that cancer cells can
recruit these protective immune cells to their own team, surrounding
them to keep back the immune system’s killer cells.
|
|
|
|
|
|
|
3.1 Tabac
|
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
|
5. Traitements
|
|
|
|
5.2 Pharma
|
|
|
Running Novartis [In the Pipeline]
|
|
|
|
|
|
The
road ahead may look wide, but it can be surprisingly narrow, and there
are deep ditches on both sides of it. These represent (for example)
letting projects go on too long, and the opposite error as well of
expecting them to deliver too soon.
|
|
|
|
|
|
|
Cometriq plays wallflower as Opdivo’s dance card fills [EP Vantage]
|
|
|
|
|
|
Cometriq
will not be able to escape comparisons with Opdivo. The first blow was
their near-simultaneous release of positive results in renal cell
carcinoma in July, and on Saturday they were put side by side in a
late-breaking data session at the European Cancer Congress in Vienna.
|
|
|
|
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
|
|
|
|
|
New treatment option for patients with rare blood cancer [EMA]
|
|
|
|
|
|
The
European Medicines Agency (EMA) has recommended granting a marketing
authorisation for Kyprolis (carfilzomib) to treat patients with multiple
myeloma whose disease has relapsed (i.e. the cancer has come back after
receiving at least one prior course of therapy). Kyprolis is for use in
combination with the cancer medicines lenalidomide and dexamethasone.
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
|
5.6.11 ESMO- Rein
|
|
|
In A First, Kidney Cancer Drug Extends Survival [Forbes]
|
|
|
|
|
|
The
NEJM has published two papers on kidney cancer treatment to coincide
with their presentation at theEuropean Cancer Congress in Vienna. While
neither study yields fantastic results, each demonstrates a significant
benefit for a new drug in patients with advanced, refractory renal cell
(kidney) tumors.
|
|
|
|
|
|
|
5.6.13 ESMO - Prostate
|
|
|
|
5.6.4 ESMO - Poumon
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
|
|
6.5 Médecines alternatives
|
|
|
|
6.8 Communication
|
|
|
Why Everything Is Bad for You [NY Times]
|
|
|
|
|
|
Like
everyone else, I believe every word in those articles. And when my gaze
reaches the fifth paragraph, the one that inevitably quotes the
university professor who has conducted the latest fear-inducing study, I
nod slightly and tell myself that somehow I knew it all along, that I
always had a feeling that this meat, or that vegetable, was quickening
my demise.
|
|
|
|
|
|